Allergy Therapeutics PLC
LSE:AGY
Income Statement
Earnings Waterfall
Allergy Therapeutics PLC
Revenue
|
53.3m
GBP
|
Cost of Revenue
|
-25.3m
GBP
|
Gross Profit
|
28m
GBP
|
Operating Expenses
|
-66.8m
GBP
|
Operating Income
|
-38.8m
GBP
|
Other Expenses
|
-11.4m
GBP
|
Net Income
|
-50.2m
GBP
|
Income Statement
Allergy Therapeutics PLC
Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||
Revenue |
21
N/A
|
23
+10%
|
24
+4%
|
26
+10%
|
26
0%
|
29
+12%
|
31
+8%
|
36
+15%
|
38
+6%
|
41
+8%
|
41
0%
|
41
+0%
|
42
+2%
|
43
+3%
|
41
-3%
|
39
-7%
|
39
+2%
|
41
+4%
|
42
+3%
|
43
+2%
|
43
+1%
|
44
+2%
|
49
+10%
|
60
+24%
|
64
+7%
|
66
+3%
|
68
+4%
|
73
+7%
|
74
+1%
|
77
+5%
|
78
+1%
|
82
+5%
|
84
+3%
|
79
-6%
|
73
-8%
|
64
-12%
|
60
-7%
|
53
-11%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(5)
|
(5)
|
(7)
|
(9)
|
(10)
|
(10)
|
(11)
|
(12)
|
(14)
|
(13)
|
(11)
|
(12)
|
(13)
|
(14)
|
(14)
|
(13)
|
(12)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(14)
|
(16)
|
(17)
|
(17)
|
(17)
|
(18)
|
(18)
|
(20)
|
(20)
|
(21)
|
(22)
|
(23)
|
(23)
|
(25)
|
(26)
|
(25)
|
|
Gross Profit |
16
N/A
|
18
+12%
|
17
-4%
|
17
-3%
|
16
-5%
|
19
+21%
|
20
+6%
|
23
+15%
|
24
+4%
|
28
+17%
|
30
+4%
|
29
-2%
|
28
-2%
|
29
+1%
|
28
-3%
|
25
-8%
|
27
+8%
|
29
+7%
|
30
+2%
|
31
+2%
|
31
+1%
|
31
+1%
|
34
+10%
|
44
+29%
|
47
+7%
|
49
+4%
|
51
+4%
|
55
+7%
|
55
+0%
|
57
+3%
|
58
+2%
|
61
+5%
|
62
+2%
|
56
-10%
|
50
-11%
|
39
-20%
|
33
-16%
|
28
-16%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(18)
|
(24)
|
(24)
|
(30)
|
(42)
|
(42)
|
(36)
|
(35)
|
(30)
|
(26)
|
(28)
|
(28)
|
(28)
|
(28)
|
(27)
|
(27)
|
(27)
|
(27)
|
(29)
|
(29)
|
(30)
|
(37)
|
(46)
|
(50)
|
(49)
|
(52)
|
(58)
|
(58)
|
(51)
|
(51)
|
(50)
|
(53)
|
(58)
|
(60)
|
(62)
|
(67)
|
(68)
|
(67)
|
|
Selling, General & Administrative |
(12)
|
(13)
|
(14)
|
(15)
|
(17)
|
(17)
|
(19)
|
(26)
|
(25)
|
(23)
|
(26)
|
(26)
|
(27)
|
(26)
|
(24)
|
(25)
|
(24)
|
(25)
|
(26)
|
(26)
|
(27)
|
(28)
|
(30)
|
(37)
|
(41)
|
(42)
|
(43)
|
(43)
|
(45)
|
(45)
|
(44)
|
(45)
|
(46)
|
(48)
|
(47)
|
(48)
|
(49)
|
(45)
|
|
Research & Development |
(6)
|
(10)
|
(10)
|
(15)
|
(25)
|
(25)
|
(16)
|
(9)
|
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(9)
|
(16)
|
(14)
|
(9)
|
(11)
|
(16)
|
(15)
|
(13)
|
(6)
|
(9)
|
(9)
|
(13)
|
(13)
|
(16)
|
(19)
|
(20)
|
(23)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
7
|
1
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Operating Income |
(2)
N/A
|
(6)
-219%
|
(7)
-16%
|
(14)
-106%
|
(26)
-90%
|
(23)
+13%
|
(16)
+32%
|
(12)
+23%
|
(6)
+48%
|
2
N/A
|
1
-39%
|
1
-34%
|
0
-88%
|
1
+609%
|
1
+41%
|
(2)
N/A
|
1
N/A
|
2
+204%
|
1
-41%
|
2
+72%
|
1
-65%
|
(5)
N/A
|
(12)
-120%
|
(6)
+49%
|
(2)
+69%
|
(3)
-43%
|
(7)
-149%
|
(2)
+64%
|
4
N/A
|
6
+47%
|
8
+29%
|
8
-3%
|
4
-50%
|
(4)
N/A
|
(12)
-183%
|
(27)
-122%
|
(35)
-28%
|
(39)
-11%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
1
|
1
|
1
|
1
|
(2)
|
(5)
|
(10)
|
(5)
|
0
|
(2)
|
(1)
|
(2)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(5)
|
|
Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(5)
|
(5)
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
Pre-Tax Income |
(2)
N/A
|
(5)
-168%
|
(6)
-19%
|
(13)
-112%
|
(26)
-96%
|
(25)
+3%
|
(20)
+19%
|
(22)
-8%
|
(11)
+48%
|
3
N/A
|
(0)
N/A
|
0
N/A
|
(2)
N/A
|
(0)
+96%
|
1
N/A
|
(2)
N/A
|
1
N/A
|
2
+260%
|
1
-43%
|
2
+82%
|
1
-67%
|
(5)
N/A
|
(12)
-121%
|
(6)
+49%
|
(2)
+68%
|
(3)
-41%
|
(7)
-149%
|
(3)
+63%
|
4
N/A
|
9
+119%
|
8
-14%
|
8
-3%
|
4
-53%
|
(5)
N/A
|
(13)
-172%
|
(28)
-122%
|
(42)
-49%
|
(48)
-16%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
1
|
3
|
2
|
(0)
|
(0)
|
(0)
|
0
|
1
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
Income from Continuing Operations |
(2)
|
(5)
|
(6)
|
(12)
|
(23)
|
(23)
|
(20)
|
(22)
|
(12)
|
3
|
1
|
0
|
(3)
|
0
|
1
|
(3)
|
1
|
2
|
1
|
2
|
0
|
(6)
|
(13)
|
(7)
|
(2)
|
(3)
|
(8)
|
(3)
|
3
|
8
|
7
|
7
|
3
|
(5)
|
(14)
|
(29)
|
(43)
|
(50)
|
|
Net Income (Common) |
(2)
N/A
|
(5)
-168%
|
(6)
-19%
|
(12)
-99%
|
(23)
-89%
|
(23)
0%
|
(20)
+13%
|
(22)
-8%
|
(12)
+47%
|
3
N/A
|
1
-80%
|
0
-71%
|
(3)
N/A
|
0
N/A
|
1
+4 000%
|
(3)
N/A
|
1
N/A
|
2
+203%
|
1
-61%
|
2
+146%
|
0
-94%
|
(6)
N/A
|
(13)
-113%
|
(7)
+44%
|
(2)
+66%
|
(3)
-33%
|
(8)
-129%
|
(3)
+57%
|
3
N/A
|
8
+143%
|
7
-16%
|
7
-5%
|
3
-57%
|
(5)
N/A
|
(14)
-156%
|
(29)
-110%
|
(43)
-49%
|
(50)
-17%
|
|
EPS (Diluted) |
-0.05
N/A
|
-0.1
-100%
|
-0.09
+10%
|
-0.16
-78%
|
-0.28
-75%
|
-0.28
N/A
|
-0.25
+11%
|
-0.27
-8%
|
-0.14
+48%
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.03
-50%
|
-0.03
N/A
|